Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis von Weiss, Lea, Weiden, Jorieke, Dölen, Yusuf, Grad, Emilia M., van Dinther, Eric A. W., Schluck, Marjolein, Eggermont, Loek J., van Mierlo, Guido, Gileadi, Uzi, Bartoló-Ibars, Ariadna, Raavé, René, Gorris, Mark A. J., Maassen, Lisa, Verrijp, Kiek, Valente, Michael, Deplancke, Bart, Verdoes, Martijn, Benitez-Ribas, Daniel, Heskamp, Sandra, van Spriel, Annemiek B., Figdor, Carl G., Hammink, Roel

Volltext

Chimeric HLA antibody receptor T cells for targeted therapy of antibody‐mediated rejection in transplantation von Betriu, Sergi, Rovira, Jordi, Arana, Carolt, García‐Busquets, Ainhoa, Matilla‐Martinez, Marina, Ramirez‐Bajo, Maria J., Bañon‐Maneus, Elisenda, Lazo‐Rodriguez, Marta, Bartoló‐Ibars, Ariadna, Claas, Frans H. J., Mulder, Arend, Heidt, Sebastiaan, Juan, Manel, Bayés‐Genís, Beatriu, Campistol, Josep M., Palou, Eduard, Diekmann, Fritz

Volltext

Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments von Ramírez-Chacón, Alejandro, Betriu-Méndez, Sergi, Bartoló-Ibars, Ariadna, González, Azucena, Martí, Mercè, Juan, Manel

Volltext

Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments von Ramírez-Chacón, Alejandro, Betriu-Méndez, Sergi, Bartoló-Ibars, Ariadna, González, Azucena, Martí, Mercè, Juan, Manel

Volltext

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies? von Bartoló-Ibars, Ariadna, Uribe-Herranz, Mireia, Muñoz-Sánchez, Guillermo, Arnaldos-Pérez, Cristina, Ortiz-Maldonado, Valentín, Urbano-Ispizua, Álvaro, Pascal, Mariona, Juan, Manel

Volltext

Immunogenicity of CD19 chimeric antigen receptor (CAR) T cells (ARI-0001) in relapsed/refractory CD19-positive B-cell malignancies recruited into the CART-BE-01 clinical trial von Bartoló Ibars, Ariadna

Volltext bestellen

Immunogenicity of CD19 chimeric antigen receptor (CAR) T cells (ARI-0001) in relapsed/refractory CD19-positive B-cell malignancies recruited into the CART-BE-01 clinical trial von Bartoló Ibars, Ariadna

Volltext bestellen

Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis von Weiss, Lea, Weiden, Jorieke, Dolen, Yusuf, Grad, Emilia M, van Dinther, Eric A.W, Schluck, Marjolein, Eggermont, Loek J, van Mierlo, Guido, Gileadi, Uzi, Bartolo-Ibars, Ariadna, Raave, Rene, Gorris, Mark A.J, Maassen, Lisa, Verrijp, Kiek, Valente, Michael, Deplancke, Bart, Verdoes, Martijn, Benitez-Ribas, Daniel, Heskamp, Sandra, van Spriel, Annemiek B, Figdor, Carl G, Hammink, Roel

Volltext

Ligand-based CAR-T cell : Different strategies to drive T cells in future new treatments von Ramírez-Chacón, Alejandro, Betriu-Méndez, Sergi, Bartoló-Ibars, Ariadna, González, Azucena, Martí, Mercè, Juan, Manel

Volltext bestellen

Ligand-based CAR-T cell : Different strategies to drive T cells in future new treatments von Ramírez-Chacón, Alejandro, Betriu-Méndez, Sergi, Bartoló-Ibars, Ariadna, González, Azucena, Martí, Mercè, Juan, Manel

Volltext bestellen

Corrigendum : Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments von Ramírez-Chacón, Alejandro, Betriu-Méndez, Sergi, Bartoló-Ibars, Ariadna, González, Azucena, Martí, Mercè, Juan, Manel

Volltext bestellen

Corrigendum : Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments von Ramírez-Chacón, Alejandro, Betriu-Méndez, Sergi, Bartoló-Ibars, Ariadna, González, Azucena, Martí, Mercè, Juan, Manel

Volltext bestellen

Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments von Ramírez Chacón, Alejandro, Betriu Méndez, Sergi, Bartoló Ibars, Ariadna, González, Azucena, Martí, Mercè, Juan, Manel

Volltext